Anti-infectives Partnering and Deal-making Conference
EARLY BIRD DISCOUNT! Register by May 9, 2014 to receive 20% off your registration!
Register 3 for the price of 2 with the coupon code RCDVB!

Overview | Speakers | Agenda | Poster Submissions | Venue | Sponsors
Dear Colleague,

GTC's 11th Anti-infectives Partnering and Deal-Making Conference, taking place on July 10-11, 2014 in Boston, MA, will contribute to the on-going battle against the ever-changing infectious threats by having experts with direct experiences in the field discuss a wide variety of topics on infectious diseases. The agenda also allows time for networking and opportunities to interface with speakers and fellow delegates in a collegial setting. Previous GTC conferences have been catalytic to several successful partnerships and in 2014 we expect this trend to continue.

GTC’s Anti-Infectives Partnering & Deal Making is an infectious disease partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant anti-infective issues and deals that will affect the industry. This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry.

2014 Interactive Panel Discussions:
  1. Pricing Strategies & Reimbursements
  2. Regulatory Guidance and Overcoming Challenges in Anti-Infectives Development
  3. Investment Opportunities & New Sources of Seed Stage Funding
  4. Finding the Middle Ground in Partnerships
  5. Licensing vs. Co-Development
  6. Future of Anti-Infective Development: Addressing Unmet Medical Need?
  7. Partnerships & Developments beyond the USA

2014 Sessions of the conference include:

  1. Antibiotic Valuation & Reimbursements
  2. Evolution of the Regulatory Framework - Streamlining Pathways for Limited Use
  3. Recent Advances in Anti-Infectives
  4. Government Collaborations & Non-dilutive Funding
  5. Recent Advances in Anti-Infectives
    Want to present at the Anti-Infective Partnering & Deal-Making Conference?
    Companies interested in presenting their programs in front of decision makers in the anti-infectives field and initiating strategic alliances can register here. Presentation slots fill up fast so please register ASAP!

The conference will run parallel with 2 other information-packed conference as part of the Infectious Diseases World Summit 2014:
12th Vaccines Research & Development: All Things Considered
3rd Influenza Research & Development

We look forward to seeing you at the conference!

Best regards,

The Advisory Committee

What past delegates said about the event:

“The GTCbio Anti-Infectives Partnering and Deal-making conference had the leaders in the field talking about very relevant areas of expertise. The opportunities for networking, business development, and dialogue with government experts were tremendous.”
- Brad Spellberg, M.D., FIDSA, FACP, Associate Professor, Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

"This was a unique and exciting conference that brought together research from universities, advice from the investment community, public-private sponsors, clinicians, and biotech and big pharma to discuss paths forward for finding new therapies for multidrug-resistant pathogens in the community and the hospital. It was not to be missed!"
- Joyce Sutcliffe, Senior Vice President, Biology, Tetraphase Pharmaceuticals

"This well-organizied conference was intimate and packed with real deal-makers and leading thinkers on the future of anti-infectives. People clearly came here for partnering, learning, and also debating the key issues of the industry. As a VC, I came away stimulated by the engaging atmosphere and positively impressed by the young companies making waves in this important field. I look forward to coming again next year."
- Kush M Parmar, MD, PhD, Principal, 5AM Ventures

"Consistently the most time effective meeting for partnering contact and information overview in the Anti-infectives space."
Klaus M. Esser, Ph.D. Co-founder & Chief Business Officer, Protez Pharmaceuticals

Brent Ahrens
Canaan Partners

Richard Bax
TranScrip Partners

Shing Chang
Formerly DNDi

Kleem Chaudhary

John Clerici
TiberCreek Partners

Danielle Drayton
Decision Resources

Barry Eisenstein

Prabhavathi Fernandes

Michael Gladstone
Atlas Venture

Peter Hammann

Laurenz Kellenberger
Basilea Pharmaceutica

Joseph Larsen

Eszter Nagy

Kush Parmar
5AM Ventures

Manos Perros

John Rex

Aram Salzman

Joyce Sutcliffe

Glenn Tillotson
TranScrip Partners

Philippe Villain-Guillot

Attend ALL GTC Conferences for One Year for only $3,995 ($1,990 for Acad/Govt).
Click here to sign up!